E-LIB Suche - Ergebnisse für: Hendrix, Craig W.

1

Phase 1 randomized trials to assess safety, pharmacokinetic..:

Achilles, Sharon L. ; Kelly, Clifton W. ; Hoesley, Craig J....
PLOS ONE. 19 (2024) 6 - p. e0304552 , 2024

Link: https://doi.org/10.1371/..

2

Pharmacokinetics of tenofovir alafenamide, emtricitabine, a..:

Massih, Sandra Abdul ; Atta, Mohamed G. ; Thio, Chloe L....
AIDS Research and Therapy. 21 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

A Phase 1 Clinical Trial to Assess the Safety and Pharmacok..:

Riddler, Sharon A ; Kelly, Clifton W ; Hoesley, Craig J...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

4

Oral preexposure prophylaxis uptake, adherence, and persist..:

Matthews, Lynn T. ; Jaggernath, Manjeetha ; Kriel, Yolandie...
AIDS. 38 (2024) 9 - p. 1342-1354 , 2024

Link: https://doi.org/10.1097/..

5

Model-based predictions of protective HIV pre-exposure prop..:

Zhang, Lanxin ; Iannuzzi, Sara ; Chaturvedula, Ayyappa...
Nature Medicine. 29 (2023) 11 - p. 2753-2762 , 2023

Link: https://doi.org/10.1038/..

6

Clinical trial simulation to evaluate tenofovir disoproxil ..:

Scott, Rachel K. ; Yu, Yifan ; Marzinke, Mark A....
Frontiers in Reproductive Health. 5 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Usin..:

Stalter, Randy M ; Dong, Tracy Q ; Hendrix, Craig W...
The Journal of Infectious Diseases. 229 (2023) 4 - p. 1158-1165 , 2023

Link: https://doi.org/10.1093/..

8

Extended Analysis of HIV Infection in Cisgender Men and Tra..:

Marzinke, Mark A. ; Fogel, Jessica M. ; Wang, Zhe...
Antimicrobial Agents and Chemotherapy. 67 (2023) 4 - p. , 2023

Link: https://doi.org/10.1128/..

9

Efficacy and safety of long-acting cabotegravir compared wi..:

Landovitz, Raphael J ; Hanscom, Brett S ; Clement, Meredith E...
The Lancet HIV. 10 (2023) 12 - p. e767-e778 , 2023

Link: https://doi.org/10.1016/..

10

Tenofovir vaginal film as a potential MPT product against H..:

Patel, Sravan Kumar ; Agashe, Hrushikesh ; Patton, Dorothy L....
Frontiers in Reproductive Health. 5 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

11

Tenofovir Douche as HIV Preexposure Prophylaxis for Recepti..:

Weld, Ethel D ; McGowan, Ian ; Anton, Peter...
The Journal of Infectious Diseases. 229 (2023) 4 - p. 1131-1140 , 2023

Link: https://doi.org/10.1093/..

12

High PrEP uptake and objective longitudinal adherence among..:

Matthews, Lynn T. ; Atukunda, Esther C. ; Owembabazi, Moran...
PLOS Medicine. 20 (2023) 2 - p. e1004088 , 2023

Link: https://doi.org/10.1371/..

13

Fundamental aspects of long-acting tenofovir alafenamide de..:

Gunawardana, Manjula ; Remedios-Chan, Mariana ; Sanchez, Debbie...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

14

Characterizing HIV-Preventive, Plasma Tenofovir Concentrati..:

Garcia-Cremades, Maria ; Vučićević, Katarina ; Hendrix, Craig W...
Clinical Infectious Diseases. 75 (2022) 11 - p. 1873-1882 , 2022

Link: https://doi.org/10.1093/..

15

Sexual behavior and medication adherence in men who have se..:

Mayer, Kenneth H. ; Yuhas, Krista ; Amico, K. Rivet...
AIDS and Behavior. , 2022

Link: https://doi.org/10.1007/..